These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 3200265

  • 1. Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight.
    Broomfield PH, Chopra R, Sheinbaum RC, Bonorris GG, Silverman A, Schoenfield LJ, Marks JW.
    N Engl J Med; 1988 Dec 15; 319(24):1567-72. PubMed ID: 3200265
    [Abstract] [Full Text] [Related]

  • 2. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
    Fromm H, Roat JW, Gonzalez V, Sarva RP, Farivar S.
    Gastroenterology; 1983 Dec 15; 85(6):1257-64. PubMed ID: 6354826
    [Abstract] [Full Text] [Related]

  • 3. Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
    Sahlin S.
    Eur J Surg; 1996 Jun 15; 162(6):463-9. PubMed ID: 8817223
    [Abstract] [Full Text] [Related]

  • 4. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss.
    Worobetz LJ, Inglis FG, Shaffer EA.
    Am J Gastroenterol; 1993 Oct 15; 88(10):1705-10. PubMed ID: 8213711
    [Abstract] [Full Text] [Related]

  • 5. The effects of ursodeoxycholic acid alone and ursodeoxycholic acid plus low-dose acetylsalicylic acid on radiolucent gallstones.
    Tuncer I, Harman M, Mercan R, Oztürk M, Arslan I, Meral C, Türkdoğan MK.
    Turk J Gastroenterol; 2003 Jun 15; 14(2):91-6. PubMed ID: 14614633
    [Abstract] [Full Text] [Related]

  • 6. Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity in gallbladder bile of patients with cholesterol gallstones.
    Jüngst C, Sreejayan N, Zündt B, Müller I, Spelsberg FW, Hüttl TP, Kullak-Ublick GA, del Pozo R, Jüngst D, von Ritter C.
    Eur J Clin Invest; 2008 Sep 15; 38(9):634-9. PubMed ID: 18837739
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and indications of ursodeoxycholic acid treatment for dissolving gallstones. A multicenter double-blind trial. Tokyo Cooperative Gallstone Study Group.
    Gastroenterology; 1980 Mar 15; 78(3):542-8. PubMed ID: 6985882
    [Abstract] [Full Text] [Related]

  • 8. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF, Thistle JL.
    Gastroenterology; 1983 Feb 15; 84(2):265-71. PubMed ID: 6848406
    [Abstract] [Full Text] [Related]

  • 9. Effect of ursodeoxycholic acid on bile supersaturated with cholesterol in patients pretreated with clofibrate.
    Kutz K, Schulte A.
    Z Gastroenterol; 1981 May 15; 19(5):231-6. PubMed ID: 7257479
    [Abstract] [Full Text] [Related]

  • 10. Low-dose ursodeoxycholic acid prolongs cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones.
    Jüngst D, Brenner G, Pratschke E, Paumgartner G.
    J Hepatol; 1989 Jan 15; 8(1):1-6. PubMed ID: 2921499
    [Abstract] [Full Text] [Related]

  • 11. Clinical perspective on the treatment of gallstones with ursodeoxycholic acid.
    Salen G.
    J Clin Gastroenterol; 1988 Jan 15; 10 Suppl 2():S12-7. PubMed ID: 3062079
    [Abstract] [Full Text] [Related]

  • 12. Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones.
    von Bergmann K, Epple-Gutsfeld M, Leiss O.
    Gastroenterology; 1984 Jul 15; 87(1):136-43. PubMed ID: 6724256
    [Abstract] [Full Text] [Related]

  • 13. Roles of deoxycholate and arachidonate in pathogenesis of cholesterol gallstones in obese patients during rapid loss of weight.
    Marks JW, Bonorris GG, Schoenfield LJ.
    Dig Dis Sci; 1991 Jul 15; 36(7):957-60. PubMed ID: 1906399
    [Abstract] [Full Text] [Related]

  • 14. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
    Stiehl A, Raedsch R, Czygan P, Götz R, Männer C, Walker S, Kommerell B.
    Gastroenterology; 1980 Dec 15; 79(6):1192-8. PubMed ID: 7439628
    [Abstract] [Full Text] [Related]

  • 15. [Lithogenicity of bile in patients after ileal resection].
    Nakano A.
    Nihon Geka Gakkai Zasshi; 1984 Dec 15; 85(12):1570-8. PubMed ID: 6527683
    [Abstract] [Full Text] [Related]

  • 16. Effect of 7-ketolithocholic acid on bile acid metabolism in humans.
    Salen G, Verga D, Batta AK, Tint GS, Shefer S.
    Gastroenterology; 1982 Aug 15; 83(2):341-7. PubMed ID: 7084613
    [Abstract] [Full Text] [Related]

  • 17. Prophylaxis against gallstone formation with ursodeoxycholic acid in patients participating in a very-low-calorie diet program.
    Shiffman ML, Kaplan GD, Brinkman-Kaplan V, Vickers FF.
    Ann Intern Med; 1995 Jun 15; 122(12):899-905. PubMed ID: 7755224
    [Abstract] [Full Text] [Related]

  • 18. Cholesterol crystals and the formation of cholesterol gallstones.
    Sedaghat A, Grundy SM.
    N Engl J Med; 1980 Jun 05; 302(23):1274-7. PubMed ID: 7366692
    [Abstract] [Full Text] [Related]

  • 19. [Nucleation time and lithogenic index in obese patients and in patients with cholecystolithiasis].
    Janowitz P, Wechsler JG, Swobodnik W, Fischer S, Förstner J, Ditschuneit H.
    Z Gastroenterol; 1988 Dec 05; 26(12):750-4. PubMed ID: 3245253
    [Abstract] [Full Text] [Related]

  • 20. [Cholesterol crystals and biliary lithiasis. Importance of the study of bile collected by duodenal intubation].
    Abbas A, Baumann R, Schutz JF, Maillard D, Sondag D, Weill JP.
    Gastroenterol Clin Biol; 1984 May 05; 8(5):454-7. PubMed ID: 6735059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.